Search All UT System Experts

Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis

Christine Bell, James Anderson, Tanmoy Ganguly, James Prescott, Ishan Capila, Jonathan C. Lansing, Richard Sachleben, Mani Iyer, Ian Fier, James Roach, Kristina Storey, Paul Miller, Steven Hall, Daniel Kantor, Benjamin M. Greenberg, Kavita Nair, Joseph Glajch

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences